The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the patient's heart.

Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.

Researchers have shed new light on how a type of heart valve disease -- aortic valve stenosis -- progresses differently in males and females. A study led by bioengineers at the University of ...

Many patients with atrial functional mitral regurgitation are not suitable candidates for surgery or transcatheter repair. For transcatheter mitral valve replacement ... absence of organic mitral ...

Abstract: Transcatheter mitral valve procedures have transformed the treatment of mitral regurgitation and stenosis by providing less invasive alternatives to conventional open-heart surgery. However, ...

The crossroads between epigenetic and immunopathways are important in inflammatory regulation, disease development, and therapeutic strategies (Figure 4). Figure 4. The crossroads of epigenetics and ...

17,18 In this regard, the goals of transcatheter therapy should be measured not only in terms ... When considering the complexity of the mitral valve apparatus, it is useful to classify the ...